DE69300451D1 - Osmotische Verrichtung zum verzögerten Aktivieren der Wirkstofffreisetzung. - Google Patents

Osmotische Verrichtung zum verzögerten Aktivieren der Wirkstofffreisetzung.

Info

Publication number
DE69300451D1
DE69300451D1 DE69300451T DE69300451T DE69300451D1 DE 69300451 D1 DE69300451 D1 DE 69300451D1 DE 69300451 T DE69300451 T DE 69300451T DE 69300451 T DE69300451 T DE 69300451T DE 69300451 D1 DE69300451 D1 DE 69300451D1
Authority
DE
Germany
Prior art keywords
drug release
osmotic device
delayed activation
time
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69300451T
Other languages
English (en)
Other versions
DE69300451T2 (de
Inventor
Patrick Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69300451D1 publication Critical patent/DE69300451D1/de
Application granted granted Critical
Publication of DE69300451T2 publication Critical patent/DE69300451T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
DE69300451T 1992-01-10 1993-01-08 Osmotische Verrichtung zum verzögerten Aktivieren der Wirkstofffreisetzung. Expired - Fee Related DE69300451T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/819,417 US5223265A (en) 1992-01-10 1992-01-10 Osmotic device with delayed activation of drug delivery
PCT/US1993/000110 WO1993013759A1 (en) 1992-01-10 1993-01-08 Osmotic device with delayed activation of drug delivery

Publications (2)

Publication Number Publication Date
DE69300451D1 true DE69300451D1 (de) 1995-10-12
DE69300451T2 DE69300451T2 (de) 1996-05-02

Family

ID=25228098

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69300451T Expired - Fee Related DE69300451T2 (de) 1992-01-10 1993-01-08 Osmotische Verrichtung zum verzögerten Aktivieren der Wirkstofffreisetzung.

Country Status (16)

Country Link
US (2) US5223265A (de)
EP (1) EP0620729B1 (de)
JP (1) JP3514756B2 (de)
KR (1) KR100246157B1 (de)
AT (1) ATE127338T1 (de)
AU (1) AU659285B2 (de)
CA (1) CA2124829C (de)
DE (1) DE69300451T2 (de)
DK (1) DK0620729T3 (de)
ES (1) ES2076837T3 (de)
FI (1) FI943280A0 (de)
MX (1) MX9300101A (de)
NO (1) NO942525L (de)
NZ (1) NZ246796A (de)
WO (1) WO1993013759A1 (de)
ZA (1) ZA93133B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728088A (en) * 1988-12-13 1998-03-17 Alza Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
SG47841A1 (en) * 1992-12-28 1998-04-17 Bausch & Lomb Controlled release composition for active substances into an aqueous medium
US5290240A (en) * 1993-02-03 1994-03-01 Pharmetrix Corporation Electrochemical controlled dispensing assembly and method for selective and controlled delivery of a dispensing fluid
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5651979A (en) * 1995-03-30 1997-07-29 Gel Sciences, Inc. Apparatus and method for delivering a biologically active compound into a biological environment
US5817335A (en) * 1995-05-26 1998-10-06 Alza Corporation Osmotic device with high drug loading and delayed activation of drug delivery
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
EP0828478B1 (de) * 1995-06-02 2002-08-07 ALZA Corporation Osmotische vorrichtung mit verzögerten aktivieren der wirkstofffreisetzung und vollständige arzneistofffreisetzung
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
KR0124764Y1 (ko) * 1995-09-23 1998-09-15 양주환 의약 및 식품용 하드 공 캅셀
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5902605A (en) * 1996-04-18 1999-05-11 Alza Corporation Drug delivery device with minimal residual drug retention
WO1998002141A1 (en) * 1996-07-15 1998-01-22 Alza Corporation Interlocking osmotic device
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6977074B2 (en) * 1997-07-10 2005-12-20 Mannkind Corporation Method of inducing a CTL response
US6994851B1 (en) 1997-07-10 2006-02-07 Mannkind Corporation Method of inducing a CTL response
MY125849A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
JP4173635B2 (ja) 1997-12-29 2008-10-29 インターシア セラピューティクス，インコーポレイティド 膜プラグ保持機構を有する浸透供給装置
ES2378675T3 (es) * 1997-12-30 2012-04-16 Intarcia Therapeutics, Inc Sistema de suministro de un agente beneficioso con una membrana obturadora
CA2316887C (en) 1997-12-31 2008-04-08 Alza Corporation Osmotic drug delivery monitoring system and method
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
CA2366791A1 (en) * 1999-04-06 2000-10-12 Kamal K. Midha Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
WO2001045675A2 (en) 1999-12-21 2001-06-28 Alza Corporation Valve for osmotic devices
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US20050070883A1 (en) * 2000-11-29 2005-03-31 Brown James E Devices and methods for controlled delivery from a drug delivery device
US6491684B1 (en) * 2001-05-22 2002-12-10 Durect Corporation Fluid delivery device having a water generating electrochemical/chemical pump and associated method
WO2003051341A1 (en) * 2001-12-18 2003-06-26 Alza Corporation Dosage form for providing time-varying patterns of drug delivery
EP1521570A1 (de) * 2002-06-28 2005-04-13 Alza Corporation, c/o Johnson & Johnson Orale dosisform, die eine flüssige formulierung eines wirkstoffes enthält und dessen freisetzung über eine erweiterungsfähige osmosezusammensetzung steuert
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
CA2534364A1 (en) * 2003-08-07 2005-02-17 Alveolus Inc. Therapeutic medical appliance, delivery and method of use
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
EP1761265A2 (de) * 2004-06-28 2007-03-14 ALZA Corporation Arzneimittel/polymer-komplex, vorzugsweise ciprofloxacin/hpmc, sein herstellungsverfahren mit lyophilisation und seine verwendung in einer osmotischen vorrichtung
JP2008510000A (ja) * 2004-08-19 2008-04-03 アルザ・コーポレーシヨン 制御放出性ナノ粒子有効薬剤配合物投与剤型品および方法
US7350479B2 (en) * 2004-09-10 2008-04-01 United States Of America As Represented By The Secretary Of The Army System and method for controlling growth of aquatic plants utilizing bio-eroding means implanted in triploid grass carp
CN101076248A (zh) * 2004-12-09 2007-11-21 塞尔基因公司 使用d－苏型哌甲酯的治疗
EP2351577A1 (de) * 2004-12-29 2011-08-03 Mannkind Corporation Verfahren zum Auslösen, Beibehalten und Manipulieren von Immunantworten durch gezielte Verabreichung von Modifikationsmitteln der biologischen Reaktion in lymphatische Organe
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
AU2006269944A1 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
CA2631233C (en) * 2005-11-28 2011-11-08 Marinus Pharmaceuticals Ganaxolone formulations and methods for the making and use thereof
US7762426B2 (en) * 2006-03-16 2010-07-27 The Procter & Gamble Company Seal for dispensing container having dispensing opening
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
EP2359808B1 (de) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotisches Verabreichungssystem mit Kolbenanordnung
WO2008066899A2 (en) 2006-11-28 2008-06-05 Marinus Pharmaceuticals Nanoparticulate formulations and methods for the making and use thereof
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
CN101827572A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放药物组合物的有板条的胶囊壳
JP5190515B2 (ja) * 2007-10-15 2013-04-24 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ 充填リンカーを製造する方法および装置
JP2011500185A (ja) * 2007-10-15 2011-01-06 グラクソ グループ リミテッド １または複数の医薬組成物を放出するためのマルチパート剤形用リンカー、およびその得られた剤形
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
EP3323423B1 (de) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
KR101914330B1 (ko) * 2011-10-06 2018-11-01 콤보캡, 인크 캡슐을 제조하는 방법 및 장치
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
WO2017062951A1 (en) 2015-10-09 2017-04-13 Binutra Incorporated Capsule with volume-adjustable internal diaphragm
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3586845A1 (de) 2016-08-11 2020-01-01 Ovid Therapeutics, Inc. Zusammensetzungen zur behandlung von essentiellem tremor
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
WO2020118142A1 (en) 2018-12-07 2020-06-11 Marinus Pharmaceuticals, Inc. Ganaxolone for use in prophylaxis and treatment of pospartum depression
JP2022543837A (ja) 2019-08-05 2022-10-14 マリナス ファーマシューティカルズ， インコーポレイテッド てんかん重積状態の治療に使用するためのガナキソロン
AU2020395254A1 (en) 2019-12-06 2022-06-02 Marinus Pharmaceuticals, Inc. Ganaxolone for use in treating tuberous sclerosis complex
WO2024075723A1 (ja) * 2022-10-07 2024-04-11 テルモ株式会社 薬剤投与装置

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034756A (en) * 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3732865A (en) * 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4595583A (en) * 1984-03-19 1986-06-17 Alza Corporation Delivery system controlled administration of beneficial agent to ruminants
US4601896A (en) * 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4955881A (en) * 1985-08-16 1990-09-11 Alza Corporation Ruminant dispensing device
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4872873A (en) * 1987-12-14 1989-10-10 Merck & Co., Inc. Controlled release bolus device
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US4976966A (en) * 1988-12-29 1990-12-11 Alza Corporation Delayed release osmotically driven fluid dispenser
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
EP0569534B1 (de) * 1991-01-30 1994-09-28 Alza Corporation Osmotische Vorrichtung für verzögerte Freisetzung eines Wirkstoffes

Also Published As

Publication number Publication date
CA2124829A1 (en) 1993-07-22
FI943280A (fi) 1994-07-08
FI943280A0 (fi) 1994-07-08
JP3514756B2 (ja) 2004-03-31
WO1993013759A1 (en) 1993-07-22
EP0620729A1 (de) 1994-10-26
KR100246157B1 (ko) 2000-04-01
ES2076837T3 (es) 1995-11-01
US5312390A (en) 1994-05-17
CA2124829C (en) 2004-03-16
AU3436893A (en) 1993-08-03
DK0620729T3 (da) 1995-12-04
EP0620729B1 (de) 1995-09-06
ZA93133B (en) 1993-08-16
MX9300101A (es) 1994-01-31
NO942525D0 (no) 1994-07-05
NZ246796A (en) 1995-10-26
ATE127338T1 (de) 1995-09-15
DE69300451T2 (de) 1996-05-02
US5223265A (en) 1993-06-29
KR940703654A (ko) 1994-12-12
JPH07504401A (ja) 1995-05-18
NO942525L (no) 1994-07-05
AU659285B2 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
DE69300451T2 (de) Osmotische Verrichtung zum verzögerten Aktivieren der Wirkstofffreisetzung.
DK0523172T3 (da) Osmotisk doseringssystem til afgivelse af flydende lægemiddel
DK0569534T3 (da) Osmotisk indretning til forsinket udlevering af et middel
NO174878C (no) Anordning for avlevering av en aktiv bestanddel til en bruksomgivelse
NO933239L (de)
HUP9902477A2 (hu) Folyadékfelszívó és testen viselhető, beültethető, aktív hatóanyagot adagoló eszközök, valamint eljárás az adagolóeszköz készítésére, továbbá vissz-diffúziót szabályozó kilépőcsatorna, féligáteresztő dugó
AR014123A1 (es) Dispositivo para dosificar una cantidad prefijada de concentrado en un pulverizador, conjunto que lo comprende y proceso que utiliza dicho dispositivo
ATE208188T1 (de) Osmotische vorrichtung mit hohem gehalt an wirkstoffen und verzögertem aktivieren der wirkstofffreisetzung
ATE221769T1 (de) Osmotische vorrichtung mit verzögerten aktivieren der wirkstofffreisetzung und vollständige arzneistofffreisetzung
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
CA2220301A1 (en) Osmotic device with delayed activation of drug delivery and complete drug release
NZ238867A (en) Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
NO20014406L (no) Doseringsaerosoler med isobutan som drivmiddel
MX9706484A (es) Forma de dosis de agente activo de liberacion prolongada con bandas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee